BIA
ASND icon

Bell Investment Advisors’s Ascendis Pharma A/S ASND Stock Holding History

Bell Investment Advisors’s Portfolio ASND Stock Details ASND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.6K Sell
21
-4
-16% -$934 ﹤0.01% 931
2026
Q1 		$5.72K Sell
25
-27
-52% -$6.05K ﹤0.01% 907
2025
Q4 		$11.1K Sell
52
-1
-2% -$207 ﹤0.01% 654
2025
Q3 		$10.5K Sell
53
-1
-2% -$187 ﹤0.01% 626
2025
Q2 		$9.32K Buy
54
+10
+23% +$1.63K ﹤0.01% 699
2025
Q1 		$6.86K Hold
44
– – ﹤0.01% 763
2024
Q4 		$6.06K Sell
44
-13
-23% -$1.71K ﹤0.01% 834
2024
Q3 		$8.51K Buy
57
+5
+10% +$675 ﹤0.01% 683
2024
Q2 		$7.09K Buy
52
+5
+11% +$680 ﹤0.01% 756
2024
Q1 		$7.11K Buy
47
+4
+9% +$571 ﹤0.01% 731
2023
Q4 		$5.42K Buy
43
+1
+2% +$100 ﹤0.01% 836
2023
Q3 		$3.93K Buy
42
+10
+31% +$936 ﹤0.01% 936
2023
Q2 		$2.86K Buy
32
+16
+100% +$1.39K ﹤0.01% 1117
2023
Q1 		$1.72K Sell
16
-31
-66% -$3.55K ﹤0.01% 1339
2022
Q4 		$5.74K Hold
47
– – ﹤0.01% 739
2022
Q3 		$5K Buy
47
+4
+9% +$379 ﹤0.01% 644
2022
Q2 		$4K Buy
+43
New +$4.05K ﹤0.01% 766
2021
Q4 		$5K Buy
35
+30
+600% +$4.46K ﹤0.01% 734
2021
Q3 		$1K Buy
+5
New +$684 ﹤0.01% 1262

Other funds holding ASND

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Bell Investment Advisors's ASND Position: Q2 2026 in Review

Bell Investment Advisors reduced its Ascendis Pharma A/S (ASND) stake by 16% in Q2 2026, selling an estimated $934 and leaving 21 shares worth $5.6K. The position accounts for ﹤0.01% of the portfolio, ranked #931.

Bell Investment Advisors first reported a position in ASND in Q3 2021 and has held it in 19 quarters since. The position peaked at $11.1K in Q4 2025. 313 funds tracked by Wall St. Rank hold ASND as of Q2 2026.

  • Bell Investment Advisors held 21 shares of Ascendis Pharma A/S worth $5.6K as of Q2 2026.
  • Bell Investment Advisors sold 4 Ascendis Pharma A/S shares in Q2 2026, an estimated $934.
  • Ascendis Pharma A/S made up ﹤0.01% of Bell Investment Advisors's portfolio in Q2 2026, its #931 holding.
  • Bell Investment Advisors first reported a position in Ascendis Pharma A/S in Q3 2021 and has held it in 19 quarters since.
  • Bell Investment Advisors's Ascendis Pharma A/S position peaked at $11.1K in Q4 2025.
  • 313 funds tracked by Wall St. Rank held Ascendis Pharma A/S as of Q2 2026.

Based on Bell Investment Advisors's 13F filing for Q2 2026, filed 7 Aug 2026.